Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

New Benchmark Could Make Pharmaceutical Companies ‘Put Their Money Where Their Mouth Is’ On Antimicrobial Resistance

Project Syndicate: Tracking Big Pharma’s Progress on AMR Jim O’Neill, honorary professor of economics at Manchester University and former chair of the Review on Antimicrobial Resistance “This week, at the World Economic Forum’s annual meeting in Davos, the Access to Medicine Foundation (AMF) is launching an antimicrobial resistance (AMR) benchmark…

Argentine Foundation Requests Government Reject Patent Request For HIV Drug Made By Gilead

SciDev.Net: Argentine NGO objects to antiretroviral patent request “An Argentine foundation has asked the National Institute of Industrial Property (INPI) to deny a patent request for an antiretroviral drug by the North American pharmaceutical company Gilead Sciences Inc. … In Brazil the same request by Gilead was rejected in 2017…”…

Large Pharmaceutical Companies Investing More In Start-Ups To Conduct Early Stage Research

CNBC: Big Pharma’s billion-dollar scramble to invest in start-ups to fuel innovation “…Despite growing recognition of [the threat of antimicrobial resistance], there is an early stage funding gap for new treatments. … In response, industry giants like Novo Holdings — which has big stakes in Danish drugmaker Novo Nordisk –…

NPR Reports On Price Differences For Medications To Treat NTDs Globally, In U.S.

NPR: Why A Pill That’s 4 Cents In Tanzania Costs Up To $400 In The U.S. “…Drugs for diseases of the developing world, in particular what are known as ‘neglected tropical diseases’ like hookworm and leishmaniasis, are enormously more expensive in the United States than in the developing world. ‘There…

Sanofi Executive Discusses Importance Of Collaborative Partnerships To Addressing Global Health Challenges

Global Health Hub: Are partnerships the key to making critical progress in Global Health? Martin Bernhardt, head of global public affairs for Sanofi’s Global Business Unit “General Medicines & Emerging Markets,” discusses the role of partnerships in addressing global health challenges. Bernhardt writes, “More than ever before, governments, industry, civil…

NTD Progress Report Shows Numbers Of People Affected By Diseases Down, 1B People Received Treatment, Challenges Remain

Los Angeles Times: Guinea worm, river blindness and elephantiasis are among the world’s neglected tropical diseases. A battle is on to wipe them out “…[T]he combined efforts of governments, nonprofit organizations, academia, and the private sector have helped combat neglected tropical diseases, or NTDs, during the last five years, according…

Postpartum Family Planning Is Key To Preventing Maternal, Infant, Child Deaths

Devex: Opinion: An untapped approach to ensure healthier mothers and babies Mindy Neiman, director of supply chain management at Merck for Mothers, and Maryjane Lacoste, senior program officer for family planning service delivery and quality at the Bill & Melinda Gates Foundation “What if we knew there was a proven…